Differential	O
inhibition	O
of	O
Smad6	B-protein
and	O
Smad7	B-protein
on	O
bone	O
morphogenetic	O
protein-	O
and	O
activin-mediated	O
growth	O
arrest	O
and	O
apoptosis	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

Smad6	B-protein
and	O
Smad7	B-protein
prevent	O
ligand-induced	O
activation	O
of	O
signal-transducing	B-protein
Smad	I-protein
proteins	I-protein
in	O
the	O
transforming	B-protein
growth	I-protein
factor-beta	I-protein
family	I-protein
.	O

Here	O
we	O
demonstrate	O
that	O
both	O
Smad6	B-protein
and	O
Smad7	B-protein
are	O
human	B-protein
bone	I-protein
morphogenetic	I-protein
protein-2	I-protein
(	O
hBMP-2	B-protein
)	O
-inducible	O
antagonists	O
of	O
hBMP-2	B-protein
-induced	O
growth	O
arrest	O
and	O
apoptosis	O
in	O
mouse	B-cell_line
B	I-cell_line
cell	I-cell_line
hybridoma	I-cell_line
HS-72	B-cell_line
cells	I-cell_line
.	O

Moreover	O
,	O
we	O
confirmed	O
that	O
the	O
ectopic	O
expressions	O
of	O
Smad6	B-protein
and	O
Smad7	B-protein
inhibited	O
the	O
hBMP-2	B-protein
-induced	O
Smad1/Smad5	B-protein
phosphorylation	O
.	O

We	O
previously	O
reported	O
that	O
Smad7	B-protein
is	O
an	O
activin	O
A-inducible	O
antagonist	O
of	O
activin	O
A-induced	O
growth	O
arrest	O
and	O
apoptosis	O
in	O
HS-72	B-cell_line
cells	I-cell_line
.	O

Interestingly	O
,	O
although	O
mRNA	O
expression	O
of	O
Smad6	B-protein
was	O
induced	O
by	O
activin	O
A	O
in	O
HS-72	B-cell_line
cells	I-cell_line
,	O
Smad6	B-protein
showed	O
no	O
antagonistic	O
effect	O
on	O
activin	O
A-induced	O
growth	O
arrest	O
and	O
apoptosis	O
.	O

Moreover	O
,	O
we	O
found	O
that	O
the	O
ectopic	O
expression	O
of	O
Smad7	B-protein
,	O
but	O
not	O
Smad6	B-protein
,	O
inhibited	O
the	O
activin	O
A-induced	O
Smad2	O
phosphorylation	O
in	O
HS-72	B-cell_line
cells	I-cell_line
.	O

Thus	O
,	O
Smad6	B-protein
and	O
Smad7	B-protein
exhibit	O
differential	O
inhibitory	O
effects	O
in	O
bone	O
morphogenetic	O
protein-2-	O
and	O
activin	O
A-mediated	O
signaling	O
in	O
B	B-cell_type
lineage	I-cell_type
cells	I-cell_type
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

274	NULL
,	NULL
No	NULL
.	NULL

19	NULL
,	NULL
Issue	NULL
of	NULL
May	NULL
7	NULL
,	NULL
pp	NULL
.	NULL

13637-13642	NULL
,	NULL
1999	NULL
Printed	NULL
in	NULL
U.S.A	NULL
.	NULL

Differential	NULL
Inhibition	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
on	NULL
Bone	NULL
Morphogenetic	NULL
Protein-	NULL
and	NULL
Activin-mediated	NULL
Growth	NULL
Arrest	NULL
and	NULL
Apoptosis	NULL
in	NULL
B	NULL
Cells*	NULL
(	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
December	NULL
4	NULL
,	NULL
1998	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
January	NULL
28	NULL
,	NULL
1999	NULL
)	NULL
Akira	NULL
Ishisaki	NULL
#	NULL
,	NULL
Kenji	NULL
Yamato§	NULL
,	NULL
Shinichi	NULL
Hashimoto	NULL
#	NULL
1	NULL
,	NULL
Atsuhito	NULL
Nakao|	NULL
,	NULL
Kiyoshi	NULL
Tamaki**	NULL
,	NULL
Koji	NULL
Nonakat	NULL
,	NULL
Peter	NULL
ten	NULL
Dijke**	NULL
,	NULL
Hiromu	NULL
Sugino	NULL
#	NULL
$	NULL
,	NULL
and	NULL
Tatsuji	NULL
From	NULL
the	NULL
{	NULL
Department	NULL
of	NULL
Oral	NULL
Science	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Infectious	NULL
Diseases	NULL
,	NULL
1-23-1	NULL
Toyama	NULL
,	NULL
Shinjuku-ku	NULL
,	NULL
Tokyo	NULL
162-8640	NULL
,	NULL
Japan	NULL
,	NULL
the	NULL
§Department	NULL
of	NULL
Molecular	NULL
Cellular	NULL
Oncology	NULL
/	NULL
Microbiology	NULL
and	NULL
the	NULL
First	NULL
Department	NULL
of	NULL
Oral	NULL
and	NULL
Maxillofacial	NULL
Surgery	NULL
,	NULL
Faculty	NULL
of	NULL
Dentistry	NULL
,	NULL
Tokyo	NULL
Medical	NULL
and	NULL
Dental	NULL
University	NULL
,	NULL
1-5-45	NULL
Yushima	NULL
,	NULL
Bunkyo-ku	NULL
,	NULL
Tokyo	NULL
113-8549	NULL
,	NULL
Japan	NULL
,	NULL
the	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Chiba	NULL
University	NULL
,	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
1-8-1	NULL
Inohana	NULL
,	NULL
Chuo-ku	NULL
,	NULL
Chiba	NULL
City	NULL
,	NULL
Chiba	NULL
260-0856	NULL
,	NULL
Japan	NULL
,	NULL
the	NULL
t	NULL
#	NULL
Institute	NULL
for	NULL
Enzyme	NULL
Research	NULL
,	NULL
University	NULL
of	NULL
Tokushima	NULL
,	NULL
3-18-15	NULL
Kuramoto	NULL
,	NULL
Tokushima	NULL
770	NULL
,	NULL
Japan	NULL
,	NULL
and	NULL
the	NULL
**Ludwig	NULL
Institute	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Box	NULL
595	NULL
,	NULL
Biomedical	NULL
Center	NULL
,	NULL
8-751	NULL
24	NULL
Uppsala	NULL
,	NULL
Sweden	NULL
Smad6	NULL
and	NULL
Smad7	NULL
prevent	NULL
ligand-induced	NULL
activation	NULL
of	NULL
signal-transducing	NULL
Smad	NULL
proteins	NULL
in	NULL
the	NULL
transforming	NULL
growth	NULL
factor-	NULL
family	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
both	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

7	NULL
are	NULL
human	NULL
bone	NULL
morphogenetic	NULL
protein-2	NULL
(	NULL
hBMP-2	NULL
)	NULL
-inducible	NULL
antagonists	NULL
of	NULL
hBMP-2-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
in	NULL
mouse	NULL
B	NULL
cell	NULL
hybridoma	NULL
HS-72	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
confirmed	NULL
that	NULL
the	NULL
ectopic	NULL
expressions	NULL
of	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

7	NULL
inhibited	NULL
the	NULL
hBMP-2-induced	NULL
Smadl/Smad5	NULL
phosphorylation	NULL
.	NULL

We	NULL
previously	NULL
reported	NULL
that	NULL
Smad	NULL
?	NULL

is	NULL
an	NULL
activin	NULL
A-induc-ible	NULL
antagonist	NULL
of	NULL
activin	NULL
A-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
although	NULL
mRNA	NULL
expression	NULL
of	NULL
Smad6	NULL
was	NULL
induced	NULL
by	NULL
activin	NULL
A	NULL
in	NULL
HS-72	NULL
cells	NULL
,	NULL
Smad6	NULL
showed	NULL
no	NULL
antagonistic	NULL
effect	NULL
on	NULL
activin	NULL
A-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
ectopic	NULL
expression	NULL
of	NULL
Smad7	NULL
,	NULL
but	NULL
not	NULL
Smad6	NULL
,	NULL
inhibited	NULL
the	NULL
activin	NULL
A-induced	NULL
Smad2	NULL
phosphorylation	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
Smad6	NULL
and	NULL
Smad7	NULL
exhibit	NULL
differential	NULL
inhibitory	NULL
effects	NULL
in	NULL
bone	NULL
morphogenetic	NULL
protein-2-	NULL
and	NULL
activin	NULL
A-mediated	NULL
signaling	NULL
in	NULL
B	NULL
lineage	NULL
cells	NULL
.	NULL

Transforming	NULL
growth	NULL
factor-B	NULL
(	NULL
TGF-	NULL
)	NULL
family	NULL
members	NULL
elicit	NULL
their	NULL
multifunctional	NULL
effects	NULL
through	NULL
heteromeric	NULL
complexes	NULL
of	NULL
type	NULL
I	NULL
and	NULL
type	NULL
II	NULL
serine/threonine	NULL
kinase	NULL
receptors	NULL
(	NULL
1-3	NULL
)	NULL
.	NULL

The	NULL
activated	NULL
type	NULL
I	NULL
receptor	NULL
then	NULL
propagates	NULL
the	NULL
signal	NULL
through	NULL
transient	NULL
interaction	NULL
with	NULL
,	NULL
and	NULL
phosphorylation	NULL
of	NULL
,	NULL
receptor-restricted	NULL
Smads	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
.	NULL

Whereas	NULL
Smad2	NULL
and	NULL
Smad3	NULL
act	NULL
in	NULL
the	NULL
TGF	NULL
-	NULL
$	NULL
and	NULL
activin	NULL
pathways	NULL
(	NULL
6-9	NULL
)	NULL
,	NULL
Smad1	NULL
,	NULL
Smad5	NULL
,	NULL
and	NULL
Smad8	NULL
act	NULL
downstream	NULL
of	NULL
bone	NULL
morphogenetic	NULL
proteins	NULL
(	NULL
BMPs	NULL
)	NULL
(	NULL
10-16	NULL
)	NULL
.	NULL

Receptor-mediated	NULL
phosphorylation	NULL
,	NULL
which	NULL
occurs	NULL
on	NULL
two	NULL
serine	NULL
residues	NULL
in	NULL
a	NULL
Ser-Ser-X-Ser	NULL
motif	NULL
at	NULL
the	NULL
end	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
Japan	NULL
Health	NULL
Science	NULL
Foundation	NULL
and	NULL
by	NULL
grants-in-aid	NULL
for	NULL
scientific	NULL
research	NULL
from	NULL
the	NULL
Ministry	NULL
of	NULL
Education	NULL
,	NULL
Science	NULL
,	NULL
and	NULL
Culture	NULL
of	NULL
Japan	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.9.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§§	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Oral	NULL
Science	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Infectious	NULL
Diseases	NULL
,	NULL
1-28-1	NULL
Toyama	NULL
,	NULL
Shinjuku-ku	NULL
,	NULL
Tokyo	NULL
162-8640	NULL
,	NULL
Japan	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
81-3-5285-1111	NULL
(	NULL
ext	NULL
.	NULL

2220	NULL
)	NULL
;	NULL
Fax	NULL
:	NULL
81-3-5285-1172	NULL
;	NULL
E-mail	NULL
:	NULL
tatsujin	NULL
@	NULL
nih.go.jp	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TGF-B	NULL
,	NULL
transforming	NULL
growth	NULL
factor-B	NULL
;	NULL
BMP	NULL
,	NULL
bone	NULL
morphogenetic	NULL
protein	NULL
;	NULL
hBMP-2	NULL
,	NULL
human	NULL
bone	NULL
morphogenetic	NULL
protein-2	NULL
;	NULL
MTT	NULL
,	NULL
3-	NULL
(	NULL
4,5-dimethylthiazol-2-yl	NULL
)	NULL
-2,5-diphenyltetrazo-lium	NULL
bromide	NULL
;	NULL
Rb	NULL
,	NULL
retinoblastoma	NULL
protein	NULL
;	NULL
pRb	NULL
,	NULL
hypophosphorylated	NULL
retinoblastoma	NULL
protein	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
of	NULL
the	NULL
C-domain	NULL
(	NULL
16-18	NULL
)	NULL
,	NULL
relieves	NULL
the	NULL
inhibitory	NULL
activity	NULL
of	NULL
the	NULL
N-domain	NULL
and	NULL
induces	NULL
homo-	NULL
and	NULL
hetero-oligomerization	NULL
with	NULL
each	NULL
other	NULL
and	NULL
with	NULL
Smad4	NULL
(	NULL
a	NULL
common	NULL
mediator	NULL
of	NULL
TGF-B	NULL
family	NULL
signaling	NULL
)	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

This	NULL
hetero-oligomeric	NULL
Smad	NULL
complex	NULL
then	NULL
translocates	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
modulates	NULL
transcription	NULL
of	NULL
TGF-B	NULL
family	NULL
target	NULL
genes	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
previously	NULL
reported	NULL
that	NULL
activin	NULL
A	NULL
induces	NULL
the	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
;	NULL
phase	NULL
and	NULL
apoptosis	NULL
in	NULL
mouse	NULL
B	NULL
cell	NULL
hybridoma	NULL
HS-72	NULL
cells	NULL
(	NULL
25	NULL
)	NULL
,	NULL
we	NULL
are	NULL
not	NULL
aware	NULL
of	NULL
any	NULL
reports	NULL
on	NULL
the	NULL
BMP-induced	NULL
growth	NULL
arrest	NULL
in	NULL
B	NULL
lineage	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
little	NULL
is	NULL
known	NULL
of	NULL
the	NULL
precise	NULL
mechanism	NULL
by	NULL
which	NULL
BMP	NULL
exerts	NULL
its	NULL
negative	NULL
growth	NULL
effect	NULL
.	NULL

We	NULL
report	NULL
here	NULL
that	NULL
BMP-2	NULL
induces	NULL
the	NULL
cell	NULL
cycle	NULL
arrest	NULL
and	NULL
apoptosis	NULL
in	NULL
B	NULL
lineage	NULL
cells	NULL
.	NULL

Smad6	NULL
and	NULL
Smad	NULL
?	NULL

function	NULL
as	NULL
inhibitors	NULL
of	NULL
TGF-	NULL
family	NULL
signaling	NULL
(	NULL
26-30	NULL
)	NULL
.	NULL

Smad	NULL
?	NULL

7	NULL
forms	NULL
stable	NULL
interactions	NULL
with	NULL
the	NULL
activated	NULL
TGF-	NULL
type	NULL
I	NULL
receptor	NULL
,	NULL
thereby	NULL
preventing	NULL
the	NULL
activation	NULL
of	NULL
receptor-restricted	NULL
Smads	NULL
by	NULL
competition	NULL
for	NULL
receptor	NULL
binding	NULL
.	NULL

Smad7	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
and	NULL
inhibit	NULL
signaling	NULL
downstream	NULL
of	NULL
BMP	NULL
receptors	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
human	NULL
Smad6	NULL
specifically	NULL
blocks	NULL
BMP	NULL
but	NULL
not	NULL
activin	NULL
signaling	NULL
in	NULL
mink	NULL
lung	NULL
epithelial	NULL
cells	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Smad6	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
BMP	NULL
receptors	NULL
,	NULL
inhibit	NULL
signaling	NULL
downstream	NULL
of	NULL
the	NULL
receptors	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
prevent	NULL
formation	NULL
of	NULL
an	NULL
active	NULL
Smad4/	NULL
Smad1	NULL
signaling	NULL
complex	NULL
by	NULL
directly	NULL
competing	NULL
with	NULL
Smad1	NULL
for	NULL
binding	NULL
to	NULL
Smad4	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Smad7	NULL
may	NULL
act	NULL
as	NULL
a	NULL
general	NULL
TGF-B	NULL
family	NULL
inhibitor	NULL
,	NULL
and	NULL
Smad6	NULL
may	NULL
have	NULL
a	NULL
tendency	NULL
to	NULL
preferentially	NULL
inhibit	NULL
the	NULL
signal	NULL
of	NULL
BMP	NULL
.	NULL

However	NULL
,	NULL
Imamura	NULL
et	NULL
al	NULL
.	NULL

(	NULL
26	NULL
)	NULL
reported	NULL
that	NULL
Smad6	NULL
partially	NULL
inhibits	NULL
the	NULL
TGF-	NULL
signal	NULL
for	NULL
phosphorylation	NULL
of	NULL
Smad2	NULL
in	NULL
COS-7	NULL
cells	NULL
and	NULL
suppresses	NULL
the	NULL
activation	NULL
of	NULL
p3TP-Lux	NULL
by	NULL
TGF-	NULL
$	NULL
stimulation	NULL
in	NULL
mink	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Nakayama	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31	NULL
)	NULL
reported	NULL
that	NULL
Xenopus	NULL
Smad6	NULL
,	NULL
which	NULL
is	NULL
52	NULL
%	NULL
identical	NULL
to	NULL
mammalian	NULL
Smad6	NULL
,	NULL
partially	NULL
blocks	NULL
the	NULL
activity	NULL
of	NULL
activin	NULL
in	NULL
a	NULL
mesoderm	NULL
induction	NULL
assay	NULL
.	NULL

We	NULL
have	NULL
reported	NULL
that	NULL
the	NULL
ectopic	NULL
expression	NULL
of	NULL
Smad	NULL
?	NULL

7	NULL
can	NULL
block	NULL
the	NULL
activin	NULL
A-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
and	NULL
apoptosis	NULL
in	NULL
mouse	NULL
B	NULL
cell	NULL
hybridoma	NULL
HS-72	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
found	NULL
that	NULL
BMP-2	NULL
also	NULL
induces	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
compared	NULL
the	NULL
effects	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
on	NULL
activin-	NULL
and	NULL
BMP-2-induced	NULL
responses	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
effects	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
on	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
pathway-restricted	NULL
Smads	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Cell	NULL
Culture-Establishment	NULL
and	NULL
characterization	NULL
of	NULL
mouse	NULL
hybridoma	NULL
HS-72	NULL
cells	NULL
and	NULL
Smad7-overexpressing	NULL
clones	NULL
(	NULL
HS-725M1	NULL
and	NULL
13637	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
13638	NULL
HS-725M2	NULL
)	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
82	NULL
,	NULL
33	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
in	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
(	NULL
Life	NULL
Technologies	NULL
,	NULL
Inc.	NULL
)	NULL
containing	NULL
10	NULL
%	NULL
heat-inactivated	NULL
fetal	NULL
calf	NULL
serum	NULL
,	NULL
100	NULL
pg/ml	NULL
streptomycin	NULL
,	NULL
and	NULL
100	NULL
units/ml	NULL
penicillin	NULL
.	NULL

Plasmid	NULL
and	NULL
Transfection-Construction	NULL
of	NULL
the	NULL
Smad6	NULL
expression	NULL
plasmid	NULL
peDNAS-FLAG-Smad6	NULL
was	NULL
reported	NULL
previously	NULL
(	NULL
26	NULL
)	NULL
.	NULL

HS-72	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
plasmid	NULL
by	NULL
electroporation	NULL
using	NULL
an	NULL
Elec-troporator	NULL
II	NULL
(	NULL
Invitrogen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
200	NULL
V	NULL
and	NULL
1000	NULL
microfarad	NULL
and	NULL
then	NULL
selected	NULL
by	NULL
cultivation	NULL
with	NULL
G418	NULL
(	NULL
1	NULL
mg/ml	NULL
)	NULL
.	NULL

Single-cell	NULL
clones	NULL
were	NULL
obtained	NULL
by	NULL
limiting	NULL
dilution	NULL
.	NULL

MTT	NULL
Assay-The	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10	NULL
%	NULL
cells/well	NULL
in	NULL
96-well	NULL
plates	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
Iscove	NULL
's	NULL
modified	NULL
Dulbecco	NULL
's	NULL
medium	NULL
containing	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
antibiotics	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
various	NULL
concentrations	NULL
of	NULL
activin	NULL
A	NULL
or	NULL
hBMP-2	NULL
for	NULL
48	NULL
h	NULL
and	NULL
then	NULL
examined	NULL
for	NULL
cell	NULL
viability	NULL
by	NULL
a	NULL
calorimetric	NULL
assay	NULL
with	NULL
MTT	NULL
(	NULL
Sigma	NULL
)	NULL
(	NULL
83	NULL
)	NULL
.	NULL

Absorbance	NULL
was	NULL
determined	NULL
at	NULL
a	NULL
wavelength	NULL
of	NULL
570	NULL
nm	NULL
with	NULL
background	NULL
subtraction	NULL
at	NULL
620	NULL
nm	NULL
.	NULL

Detection	NULL
of	NULL
Apoptotic	NULL
Cells-To	NULL
detect	NULL
apoptotic	NULL
nuclei	NULL
,	NULL
the	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10°	NULL
)	NULL
were	NULL
suspended	NULL
in	NULL
a	NULL
hypotonic	NULL
solution	NULL
(	NULL
8.4	NULL
mM	NULL
sodium	NULL
citrate	NULL
,	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
0.1	NULL
mM	NULL
EDTA	NULL
,	NULL
1	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
8.0	NULL
)	NULL
)	NULL
,	NULL
stained	NULL
with	NULL
5	NULL
ug/ml	NULL
propidium	NULL
iodide	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
a	NULL
FACSCalibur	NULL
(	NULL
Becton	NULL
Dickinson	NULL
Immunocytometry	NULL
Systems	NULL
,	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
(	NULL
84	NULL
)	NULL
.	NULL

In	NULL
the	NULL
DNA	NULL
fragmentation	NULL
assay	NULL
,	NULL
the	NULL
DNA	NULL
was	NULL
extracted	NULL
from	NULL
HS-72	NULL
cells	NULL
(	NULL
5	NULL
X	NULL
10°	NULL
)	NULL
according	NULL
to	NULL
the	NULL
method	NULL
of	NULL
Moore	NULL
and	NULL
Matiashewski	NULL
(	NULL
85	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
electrophoresed	NULL
in	NULL
a	NULL
2	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
stained	NULL
with	NULL
ethidium	NULL
bromide	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
Immunoblot	NULL
Analysis-Anti-FLAG	NULL
monoclonal	NULL
antibody	NULL
(	NULL
anti-FLAG	NULL
M2	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Eastman	NULL
Kodak	NULL
Co.	NULL
Anti-retinoblastoma	NULL
protein	NULL
(	NULL
Rb	NULL
)	NULL
monoclonal	NULL
antibody	NULL
(	NULL
G8-245	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Anti-p21°	NULL
``	NULL
``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Ab-4	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem-Novabiochem	NULL
.	NULL

Anti-mouse	NULL
Smad2	NULL
monoclonal	NULL
antibody	NULL
was	NULL
purchased	NULL
from	NULL
Transduc-tion	NULL
Laboratories	NULL
(	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
.	NULL

The	NULL
antibody	NULL
against	NULL
phosphorylated	NULL
Smad2	NULL
was	NULL
raised	NULL
after	NULL
immunizing	NULL
rabbits	NULL
with	NULL
the	NULL
synthetic	NULL
peptide	NULL
(	NULL
KKKSSMS	NULL
)	NULL
phosphorylated	NULL
at	NULL
the	NULL
last	NULL
two	NULL
serine	NULL
residues	NULL
coupled	NULL
to	NULL
keyhole	NULL
limpet	NULL
hemocyanin	NULL
as	NULL
previously	NULL
reported	NULL
(	NULL
9	NULL
,	NULL
36	NULL
)	NULL
.	NULL

This	NULL
antibody	NULL
specifically	NULL
recognizes	NULL
Smad2	NULL
phosphorylated	NULL
by	NULL
activated	NULL
type	NULL
I	NULL
receptor	NULL
(	NULL
86	NULL
)	NULL
.	NULL

The	NULL
antibody	NULL
against	NULL
phosphorylated	NULL
Smad1/	NULL
Smad5	NULL
was	NULL
raised	NULL
against	NULL
KKKNPISSVS	NULL
phosphorylated	NULL
at	NULL
the	NULL
last	NULL
two	NULL
serine	NULL
residues	NULL
and	NULL
specifically	NULL
recognizes	NULL
Smad1	NULL
and	NULL
Smad5	NULL
phosphorylated	NULL
by	NULL
an	NULL
activated	NULL
type	NULL
I	NULL
receptor	NULL
(	NULL
36	NULL
)	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
7.5	NULL
)	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
mM	NULL
phenyl-methylsulfonyl	NULL
fluoride	NULL
,	NULL
and	NULL
a	NULL
protease	NULL
inhibitor	NULL
mixture	NULL
)	NULL
(	NULL
complete	NULL
,	NULL
EDTA-free	NULL
;	NULL
Roche	NULL
Molecular	NULL
Biochemicals	NULL
)	NULL
.	NULL

The	NULL
extracted	NULL
protein	NULL
(	NULL
600	NULL
ug	NULL
)	NULL
was	NULL
reacted	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
goat	NULL
anti-Smadl/Smad5	NULL
serum	NULL
(	NULL
N-18	NULL
,	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
,	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
at	NULL
4	NULL
°C	NULL
for	NULL
1	NULL
h	NULL
and	NULL
then	NULL
incubated	NULL
with	NULL
20	NULL
ul	NULL
of	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
on	NULL
ice	NULL
for	NULL
1	NULL
h	NULL
with	NULL
gentle	NULL
agitation	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
with	NULL
lysis	NULL
buffer	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
below	NULL
.	NULL

For	NULL
immunoblotting	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
(	NULL
pH	NULL
6.8	NULL
)	NULL
and	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
boiled	NULL
for	NULL
5	NULL
min	NULL
,	NULL
and	NULL
then	NULL
centrifuged	NULL
at	NULL
12,000	NULL
%	NULL
g.	NULL
The	NULL
extracted	NULL
proteins	NULL
(	NULL
60	NULL
pug	NULL
)	NULL
in	NULL
supernatants	NULL
were	NULL
separated	NULL
by	NULL
polyacrylamide	NULL
gels	NULL
containing	NULL
0.1	NULL
%	NULL
SDS	NULL
and	NULL
then	NULL
electroblotted	NULL
on	NULL
polyvinylidine	NULL
fluoride	NULL
membranes	NULL
(	NULL
Millipore	NULL
Corp.	NULL
,	NULL
Bedford	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

Im-munodetection	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
ECL	NULL
Western	NULL
blotting	NULL
detection	NULL
system	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Blots	NULL
were	NULL
stained	NULL
with	NULL
Coo-massie	NULL
Brilliant	NULL
Blue	NULL
,	NULL
and	NULL
each	NULL
lane	NULL
was	NULL
confirmed	NULL
to	NULL
contain	NULL
a	NULL
similar	NULL
amount	NULL
of	NULL
protein	NULL
.	NULL

Northern	NULL
Blot	NULL
Analysis-Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
the	NULL
cells	NULL
using	NULL
an	NULL
Isogen	NULL
RNA	NULL
extraction	NULL
kit	NULL
(	NULL
Nippon	NULL
Gene	NULL
,	NULL
Tokyo	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
electrophoresed	NULL
in	NULL
a	NULL
formaldehyde-agarose	NULL
gel	NULL
and	NULL
blotted	NULL
on	NULL
a	NULL
nylon	NULL
membrane	NULL
(	NULL
Hybond-N*	NULL
,	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Mouse	NULL
Smad6	NULL
,	NULL
mouse	NULL
Smad7	NULL
,	NULL
mouse	NULL
p21°*'**	NULL
``	NULL
*	NULL
``	NULL
,	NULL
and	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
cDNA	NULL
fragments	NULL
were	NULL
isolated	NULL
from	NULL
-	NULL
peDNAS-FLAG-Smad6	NULL
(	NULL
26	NULL
)	NULL
,	NULL
peDNAS-FLAG-Smad7	NULL
(	NULL
28	NULL
)	NULL
,	NULL
pCMW35T3	NULL
,	NULL
and	NULL
pKS821	NULL
(	NULL
87	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
labeled	NULL
with	NULL
[	NULL
a-°P	NULL
]	NULL
dCTP	NULL
using	NULL
a	NULL
Multiprime	NULL
``	NULL
``	NULL
DNA	NULL
labeling	NULL
system	NULL
(	NULL
Amersham	NULL
Pharmacia	NULL
Biotech	NULL
)	NULL
.	NULL

Hybridization	NULL
and	NULL
washing	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
88	NULL
)	NULL
.	NULL

RESULTS	NULL
Activin	NULL
A	NULL
and	NULL
BMP-2	NULL
Induce	NULL
Inhibitory	NULL
Smad	NULL
mRNA	NULL
Ex-pression-Northern	NULL
blot	NULL
analysis	NULL
of	NULL
Smad7	NULL
revealed	NULL
that	NULL
Smad7	NULL
mRNA	NULL
was	NULL
induced	NULL
in	NULL
HS-72	NULL
cells	NULL
stimulated	NULL
with	NULL
either	NULL
hBMP-2	NULL
or	NULL
activin	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
Smad	NULL
?	NULL

7	NULL
mRNA	NULL
was	NULL
most	NULL
prominently	NULL
induced	NULL
after	NULL
1	NULL
h	NULL
of	NULL
hBMP-2	NULL
or	NULL
activin	NULL
A	NULL
stimulation	NULL
and	NULL
decreased	NULL
time	NULL
dependently	NULL
.	NULL

North	NULL
Distinct	NULL
Functional	NULL
Roles	NULL
for	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

A	NULL
HS-72	NULL
hBMP-2	NULL
-	NULL
Activin	NULL
A	NULL
0	NULL
14	NULL
3	NULL
6	NULL
14	NULL
3	NULL
6	NULL
h	NULL
2s	NULL
-	NULL
-	NULL
\	NULL
188	NULL
W	NULL
«	NULL
»	NULL
«	NULL
<	NULL
-	NULL
Smad7	NULL
e0090008	NULL
0	NULL
csson	NULL
B	NULL
HS-72	NULL
hBMP-2	NULL
_	NULL
Activin	NULL
A	NULL
0	NULL
4	NULL
3	NULL
6	NULL
1	NULL
3	NULL
6	NULL
h	NULL
28S	NULL
W	NULL
W	NULL
©	NULL
O	NULL
@	NULL
<	NULL
-	NULL
smads	NULL
188	NULL
00000	NULL
o	NULL
a	NULL
caro	NULL
:	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Activin	NULL
A	NULL
and	NULL
hBMP-2	NULL
induce	NULL
Smad6	NULL
and	NULL
Smad7	NULL
mRNA	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

HS-72	NULL
cells	NULL
were	NULL
exposed	NULL
to	NULL
activin	NULL
A	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
or	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
various	NULL
times	NULL
.	NULL

The	NULL
total	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
separated	NULL
and	NULL
analyzed	NULL
for	NULL
levels	NULL
of	NULL
Smad7	NULL
(	NULL
A	NULL
)	NULL
and	NULL
Smad6	NULL
(	NULL
B	NULL
)	NULL
mRNA	NULL
by	NULL
Northern	NULL
blotting	NULL
.	NULL

The	NULL
same	NULL
blot	NULL
was	NULL
serially	NULL
hybridized	NULL
with	NULL
a	NULL
glyceraldehyde-3-phosphate	NULL
dehydrogenase	NULL
(	NULL
GAPDH	NULL
)	NULL
cDNA	NULL
probe	NULL
.	NULL

ern	NULL
blot	NULL
analysis	NULL
of	NULL
Smad6	NULL
revealed	NULL
that	NULL
Smad6	NULL
mRNA	NULL
was	NULL
induced	NULL
in	NULL
HS-72	NULL
cells	NULL
stimulated	NULL
with	NULL
either	NULL
hBMP-2	NULL
or	NULL
activin	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Maximal	NULL
levels	NULL
of	NULL
Smad6	NULL
mRNA	NULL
expression	NULL
were	NULL
achieved	NULL
after	NULL
3	NULL
h	NULL
of	NULL
stimulation	NULL
with	NULL
either	NULL
activin	NULL
A	NULL
or	NULL
hBMP-2	NULL
.	NULL

Effects	NULL
of	NULL
Inhibitory	NULL
Smads	NULL
on	NULL
BMP-2-	NULL
and	NULL
Activin	NULL
A-induced	NULL
Growth	NULL
Arrest-To	NULL
investigate	NULL
whether	NULL
Smad6	NULL
controls	NULL
the	NULL
growth	NULL
arrest	NULL
induced	NULL
by	NULL
activin	NULL
A	NULL
or	NULL
hBMP-2	NULL
,	NULL
HS-72	NULL
cells	NULL
were	NULL
stably	NULL
transfected	NULL
with	NULL
mouse	NULL
Smad6	NULL
expression	NULL
plasmid	NULL
(	NULL
peDNA3-FLAG-Smad6	NULL
)	NULL
.	NULL

Two	NULL
clones	NULL
(	NULL
HS-72Sma6A	NULL
and	NULL
HS-728ma6B	NULL
)	NULL
were	NULL
found	NULL
to	NULL
express	NULL
high	NULL
levels	NULL
(	NULL
66	NULL
kDa	NULL
)	NULL
of	NULL
mouse	NULL
FLAG-Smad6	NULL
(	NULL
Fig	NULL
.	NULL

24	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
FLAG-Smad6	NULL
in	NULL
HS-728ma6A	NULL
and	NULL
HS-728ma6B	NULL
were	NULL
similar	NULL
to	NULL
those	NULL
of	NULL
FLAG-Smad	NULL
?	NULL

7	NULL
in	NULL
HS-728M1	NULL
and	NULL
HS-728M2	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
Smad7	NULL
controls	NULL
the	NULL
growth	NULL
arrest	NULL
induced	NULL
by	NULL
hBMP-2	NULL
,	NULL
Smad	NULL
clones	NULL
(	NULL
HS-728M1	NULL
and	NULL
HS-728M2	NULL
)	NULL
and	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
were	NULL
stimulated	NULL
with	NULL
hBMP-2	NULL
.	NULL

A	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
showed	NULL
growth	NULL
arrest	NULL
in	NULL
response	NULL
to	NULL
hBMP-2	NULL
.	NULL

Smad7-overexpressing	NULL
clones	NULL
(	NULL
HS-728SM1	NULL
and	NULL
HS-728SM2	NULL
)	NULL
showed	NULL
no	NULL
growth	NULL
arrest	NULL
in	NULL
response	NULL
to	NULL
hBMP-2	NULL
in	NULL
MTT	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
Smad6	NULL
controls	NULL
the	NULL
growth	NULL
arrest	NULL
induced	NULL
by	NULL
hBMP-2	NULL
or	NULL
activin	NULL
A.	NULL
Smad6-expressing	NULL
clones	NULL
(	NULL
HS-728Sma6A	NULL
and	NULL
HS-728Sma6B	NULL
)	NULL
showed	NULL
no	NULL
growth	NULL
arrest	NULL
in	NULL
response	NULL
to	NULL
hBMP	NULL
in	NULL
MTT	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
Smad6-expressing	NULL
clones	NULL
(	NULL
HS-72Sma6A	NULL
and	NULL
HS-728ma6B	NULL
)	NULL
showed	NULL
remarkable	NULL
growth	NULL
arrest	NULL
in	NULL
response	NULL
to	NULL
activin	NULL
A	NULL
(	NULL
Fig	NULL
.	NULL

2D	NULL
)	NULL
.	NULL

Cultivation	NULL
with	NULL
hBMP-2	NULL
for	NULL
24	NULL
h	NULL
increased	NULL
the	NULL
population	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
from	NULL
16.8	NULL
to	NULL
89.9	NULL
%	NULL
with	NULL
a	NULL
reduction	NULL
of	NULL
those	NULL
in	NULL
the	NULL
S	NULL
phase	NULL
from	NULL
76.1	NULL
to	NULL
3.3	NULL
%	NULL
in	NULL
HS-72C4	NULL
clone	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
hBMP-2	NULL
showed	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
cell	NULL
cycle	NULL
distribution	NULL
of	NULL
Smad7-overexpressing	NULL
clones	NULL
(	NULL
HS-72SM1	NULL
and	NULL
HS-728M2	NULL
)	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
II	NULL
,	NULL
cultivation	NULL
with	NULL
activin	NULL
A	NULL
for	NULL
24	NULL
h	NULL
increased	NULL
the	NULL
population	NULL
of	NULL
cells	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
from	NULL
17.0	NULL
to	NULL
67.8	NULL
%	NULL
with	NULL
a	NULL
reduction	NULL
of	NULL
those	NULL
in	NULL
the	NULL
S	NULL
phase	NULL
from	NULL
74.5	NULL
to	NULL
23.2	NULL
%	NULL
in	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
,	NULL
indicating	NULL
the	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
.	NULL

Activin	NULL
A	NULL
treatment	NULL
also	NULL
induced	NULL
the	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
in	NULL
Smad6-overexpressing	NULL
clones	NULL
(	NULL
HS-728ma6A	NULL
and	NULL
HS-72Sma6B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
hBMP-2	NULL
showed	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
cell	NULL
cycle	NULL
distribution	NULL
of	NULL
Smad6G-overexpressing	NULL
clones	NULL
(	NULL
HS-72Sma6A	NULL
and	NULL
HS-728ma6B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
overexpression	NULL
of	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

7	NULL
in	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Distinct	NULL
Functional	NULL
Roles	NULL
for	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

HS-72	NULL
HS-72C4	NULL
HS-725M1	NULL
HS-725M2	NULL
HS-72Sma6A	NULL
HS-72Sma6B	NULL
kDa	NULL
66	NULL
-	NULL
-a-	NULL
Smadé	NULL
46	NULL
-	NULL
wae	NULL
a	NULL
-a-	NULL
Smad	NULL
?	NULL

Percent	NULL
viability	NULL
hBMP-2	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

13639	NULL
B	NULL
120	NULL
100	NULL
P	NULL
P	NULL
P	NULL
o	NULL
o	NULL
o	NULL
i	NULL
i	NULL
i	NULL
Percent	NULL
viability	NULL
io	NULL
o	NULL
i	NULL
3	NULL
T	NULL
r	NULL
t	NULL
t	NULL
a	NULL
10	NULL
20	NULL
30	NULL
40	NULL
50	NULL
hBMP-2	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

A_	NULL
r	NULL
t	NULL
r	NULL
o	NULL
10	NULL
20	NULL
30	NULL
«	NULL
0	NULL
so	NULL
Activin	NULL
A	NULL
(	NULL
ng/m	NULL
!	NULL
)	NULL

Percent	NULL
viability	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Effects	NULL
of	NULL
ectopic	NULL
expression	NULL
of	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

on	NULL
growth	NULL
arrest	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

HS-72	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
plasmid	NULL
peDNAS-FLAG-Smad6	NULL
.	NULL

FLAG-Smad6	NULL
and	NULL
FLAG-Smad7	NULL
expressions	NULL
were	NULL
detected	NULL
using	NULL
an	NULL
anti-FLAG	NULL
monoclonal	NULL
antibody	NULL
by	NULL
immunoblotting	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
various	NULL
concentrations	NULL
of	NULL
hBMP-2	NULL
(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
or	NULL
activin	NULL
A	NULL
(	NULL
D	NULL
)	NULL
for	NULL
48	NULL
h	NULL
,	NULL
and	NULL
the	NULL
cell	NULL
viabilities	NULL
were	NULL
monitored	NULL
by	NULL
MTT	NULL
assay	NULL
.	NULL

Percent	NULL
viability	NULL
was	NULL
calculated	NULL
by	NULL
the	NULL
following	NULL
formula	NULL
:	NULL
percent	NULL
viability	NULL
=	NULL
100	NULL
X	NULL
(	NULL
4579_s20	NULL
nm	NULL
With	NULL
BBMP	NULL
am	NULL
Without	NULL
hBMP-2	NULL
)	NULL
.	NULL

Closed	NULL
triangle	NULL
,	NULL
HS-72C4	NULL
;	NULL
open	NULL
triangle	NULL
,	NULL
HS-728M1	NULL
;	NULL
x	NULL
,	NULL
HS-7285M2	NULL
;	NULL
open	NULL
circle	NULL
,	NULL
HS-725ma6A	NULL
;	NULL
open	NULL
square	NULL
,	NULL
HS-728ma6B	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
triplicate	NULL
cultures	NULL
.	NULL

The	NULL
experiment	NULL
was	NULL
performed	NULL
three	NULL
times	NULL
and	NULL
similar	NULL
results	NULL
were	NULL
obtained	NULL
from	NULL
each	NULL
experiment	NULL
.	NULL

TaBLE	NULL
I	NULL
Effects	NULL
of	NULL
Smad7	NULL
on	NULL
hBMP-2-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
triplicate	NULL
cultures	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
24	NULL
h.	NULL
Cell	NULL
cycle	NULL
distributions	NULL
Clones	NULL
Stimulation	NULL
ea	NULL
G	NULL
,	NULL
/M	NULL
sl	NULL
%	NULL
HS-7204	NULL
-*	NULL
16.8	NULL
+	NULL
0.5	NULL
7.1	NULL
+14	NULL
76.1	NULL
+11	NULL
BMP	NULL
89.9	NULL
+	NULL
0.8	NULL
6.8	NULL
+	NULL
0.7	NULL
8.3	NULL
+	NULL
0.1	NULL
HS-728M1	NULL
-	NULL
24.17	NULL
+	NULL
1.8	NULL
9.6	NULL
+	NULL
0.6	NULL
65.8	NULL
+	NULL
1.0	NULL
BMP	NULL
28.9	NULL
+	NULL
0.8	NULL
10.4	NULL
£	NULL
0.8	NULL
65.7	NULL
+	NULL
0.7	NULL
HS-7285M2	NULL
-	NULL
28.6	NULL
+	NULL
0.9	NULL
114	NULL
+	NULL
0.5	NULL
60.0	NULL
+	NULL
0.9	NULL
BMP	NULL
28	NULL
4	NULL
+	NULL
0.7	NULL
11.8	NULL
£	NULL
0.6	NULL
59.7	NULL
+	NULL
0.7	NULL
*	NULL
Dash	NULL
indicates	NULL
without	NULL
stimulation	NULL
.	NULL

HS-72	NULL
cells	NULL
abolish	NULL
the	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
induced	NULL
by	NULL
hBMP-2	NULL
and	NULL
that	NULL
overexpression	NULL
of	NULL
Smad6	NULL
in	NULL
HS-72	NULL
cells	NULL
does	NULL
not	NULL
abolish	NULL
the	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
induced	NULL
by	NULL
activin	NULL
A	NULL
.	NULL

Effects	NULL
of	NULL
Inhibitory	NULL
Smads	NULL
on	NULL
BMP-2-	NULL
and	NULL
Activin	NULL
A-induced	NULL
Changes	NULL
in	NULL
p21	NULL
``	NULL
obtain	NULL
more	NULL
insight	NULL
into	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
Smad7	NULL
suppresses	NULL
hBMP-2-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
Smad	NULL
?	NULL

7	NULL
on	NULL
the	NULL
BMP-2-induced	NULL
expression	NULL
of	NULL
p21	NULL
``	NULL
by	NULL
immunoblot	NULL
analysis	NULL
.	NULL

The	NULL
untreated	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
showed	NULL
undetectable	NULL
levels	NULL
of	NULL
p21C	NULL
``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
by	NULL
immunoblot	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Upon	NULL
exposure	NULL
to	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
,	NULL
expression	NULL
of	NULL
p21°_*	NULL
``	NULL
*4	NULL
``	NULL
``	NULL
(	NULL
21	NULL
kDa	NULL
)	NULL
was	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
6	NULL
h	NULL
,	NULL
and	NULL
its	NULL
level	NULL
increased	NULL
time	NULL
dependently	NULL
in	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
SmadT7-overexpressing	NULL
clones	NULL
(	NULL
HS-	NULL
TaBLE	NULL
II	NULL
Effects	NULL
of	NULL
Smad6	NULL
on	NULL
hBMP-2-	NULL
or	NULL
activin	NULL
A-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
Data	NULL
are	NULL
expressed	NULL
as	NULL
the	NULL
means	NULL
+	NULL
S.D	NULL
.	NULL

of	NULL
triplicate	NULL
cultures	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
hBMP-2	NULL
or	NULL
activin	NULL
A	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
24	NULL
h.	NULL
Cell	NULL
cycle	NULL
distributions	NULL
Clones	NULL
Stimulation	NULL
ea	NULL
G/M	NULL
sl	NULL
%	NULL
HS-7204	NULL
-*	NULL
17.0	NULL
+	NULL
0.6	NULL
8A	NULL
+	NULL
0.7	NULL
74.5	NULL
£	NULL
0.6	NULL
BMP	NULL
91.1	NULL
+	NULL
1.1	NULL
5.7	NULL
+	NULL
0.7	NULL
8.2	NULL
+	NULL
0.8	NULL
Activin	NULL
67.8	NULL
+	NULL
1.0	NULL
8.9	NULL
+	NULL
0.5	NULL
28.2	NULL
+	NULL
0.6	NULL
HS-725ma6A	NULL
-	NULL
20.1	NULL
+	NULL
1.0	NULL
9.1	NULL
+	NULL
1.0	NULL
70.8	NULL
+	NULL
1.6	NULL
BMP	NULL
21.3	NULL
+	NULL
0.8	NULL
10.2	NULL
£	NULL
0.6	NULL
68.5	NULL
+	NULL
0.4	NULL
Activin	NULL
61.7	NULL
+	NULL
1.8	NULL
12.7	NULL
+	NULL
1.0	NULL
25.6	NULL
+	NULL
0.9	NULL
HS-725ma6B	NULL
-	NULL
19.6	NULL
+	NULL
0.7	NULL
11.6	NULL
+	NULL
0.4	NULL
68.8	NULL
£	NULL
0.5	NULL
BMP	NULL
194	NULL
+	NULL
0.6	NULL
11.1	NULL
+	NULL
1.0	NULL
68.8	NULL
£	NULL
0.5	NULL
Activin	NULL
61.7	NULL
+11	NULL
9.9	NULL
+0.6	NULL
28.4	NULL
+	NULL
1.2	NULL
*	NULL
Dash	NULL
indicates	NULL
without	NULL
stimulation	NULL
.	NULL

728M1	NULL
and	NULL
HS-728M2	NULL
)	NULL
contained	NULL
undetectable	NULL
levels	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
when	NULL
cultured	NULL
with	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
Smad	NULL
?	NULL

on	NULL
the	NULL
hBMP-2-induced	NULL
hypophosphorylation	NULL
of	NULL
Rb	NULL
by	NULL
immunoblot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
decreased	NULL
the	NULL
levels	NULL
of	NULL
hyperphosphorylated	NULL
Rb	NULL
in	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
at	NULL
12	NULL
and	NULL
24	NULL
h	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
time-dependent	NULL
increase	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
hypophosphorylated	NULL
Rb	NULL
(	NULL
pRb	NULL
)	NULL
.	NULL

However	NULL
,	NULL
hBMP-2	NULL
showed	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
Rb	NULL
in	NULL
Smad7-expressing	NULL
clones	NULL
(	NULL
HS-72SM1	NULL
and	NULL
HS-72SM2	NULL
)	NULL
during	NULL
a	NULL
24-h	NULL
culture	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
Smad6	NULL
on	NULL
hBMP-2	NULL
and	NULL
the	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
13640	NULL
A	NULL
HS-72c4	NULL
__	NULL
HS-T2SM1	NULL
__	NULL
HS-72SM2	NULL
0	NULL
6	NULL
12	NULL
24	NULL
0	NULL
6	NULL
12	NULL
24	NULL
0	NULL
6	NULL
42	NULL
24	NULL
h	NULL
kDa	NULL
p21	NULL
CIPUWAFI	NULL
-e-	NULL
w-	NULL
am	NULL
__	NULL
-21.5	NULL
-14.5	NULL
ppRb	NULL
(	NULL
110	NULL
kDa	NULL
)	NULL
s___	NULL
.	NULL

gos	NULL
hue	NULL
pRb	NULL
(	NULL
105	NULL
kDa	NULL
)	NULL
~-	NULL
Wil	NULL
uas	NULL
--	NULL
66	NULL
B	NULL
HS-72C4	NULL
_	NULL
HS-72	NULL
$	NULL
ma6A	NULL
-	NULL
HS-72Sma6B	NULL
0	NULL
6	NULL
12	NULL
24	NULL
0	NULL
6	NULL
12	NULL
24	NULL
0	NULL
6	NULL
12	NULL
24	NULL
h	NULL
kDa	NULL
p21CIPUWAFT	NULL
-z	NULL
won	NULL
cum	NULL
mm	NULL
-21.5	NULL
-14.5	NULL
ppRb	NULL
(	NULL
110	NULL
kDa	NULL
)	NULL
pRb	NULL
{	NULL
105kna	NULL
}	NULL
/	NULL
’	NULL
_-l-—	NULL
:	NULL
—-	NULL
wan	NULL
mas	NULL
uae	NULL
cae	NULL
Gub	NULL
#	NULL
A	NULL
_	NULL
;	NULL
;	NULL
-66	NULL
C	NULL
HS-7204	NULL
0	NULL
6	NULL
12	NULL
24	NULL
0	NULL
6	NULL
12	NULL
24	NULL
0	NULL
6	NULL
12	NULL
24	NULL
h	NULL
HS-72Sma6A	NULL
-	NULL
HS-725ma6B	NULL
kDa	NULL
pQ	NULL
‘	NULL
CIPIM	NULL
‘	NULL
nFI	NULL
-	NULL
»	NULL
Ste	NULL
tues	NULL
=	NULL
_	NULL
.	NULL

=-	NULL
-21.5	NULL
coa	NULL
uas	NULL
>	NULL
a	NULL
*	NULL
>	NULL
fae	NULL
an	NULL
-14.5	NULL
ppRb	NULL
(	NULL
110	NULL
kDa	NULL
)	NULL
a	NULL
%	NULL
F	NULL
_	NULL
1	NULL
ar	NULL
pRb	NULL
(	NULL
105	NULL
kDa	NULL
)	NULL
~	NULL
-	NULL
Wilk	NULL
Ath	NULL
mae	NULL
.	NULL

#	NULL
5	NULL
Sse	NULL
--	NULL
97	NULL
-66	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Effects	NULL
of	NULL
ectopic	NULL
expression	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
on	NULL
the	NULL
expression	NULL
and	NULL
Rb	NULL
hypophosphorylation	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
or	NULL
activin	NULL
A	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
(	NULL
C	NULL
)	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

p21	NULL
``	NULL
***	NULL
``	NULL
and	NULL
Rb	NULL
expression	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
.	NULL

activin	NULL
A-induced	NULL
expression	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
*	NULL
``	NULL
``	NULL
``	NULL
by	NULL
immunoblot	NULL
analysis	NULL
.	NULL

Smad6-overexpressing	NULL
clones	NULL
(	NULL
HS-72Sma6A	NULL
and	NULL
HS-728ma6B	NULL
)	NULL
contained	NULL
undetectable	NULL
levels	NULL
of	NULL
pZICIP	NULL
1/WAF1	NULL
when	NULL
cultured	NULL
with	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

hBMP-2	NULL
did	NULL
not	NULL
change	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
Rb	NULL
in	NULL
SmadG-overexpressing	NULL
clones	NULL
(	NULL
HS-72Sma6A	NULL
and	NULL
HS-728ma6B	NULL
)	NULL
during	NULL
a	NULL
24-h	NULL
culture	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
an	NULL
expression	NULL
of	NULL
WA*	NULL
!	NULL

was	NULL
detected	NULL
in	NULL
12-	NULL
and	NULL
24-h	NULL
cultures	NULL
of	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
and	NULL
Smad6G-overexpressing	NULL
clones	NULL
(	NULL
HS-728Sma6A	NULL
and	NULL
HS-72Sma6B	NULL
)	NULL
upon	NULL
exposure	NULL
to	NULL
activin	NULL
A	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
activin	NULL
A	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
decreased	NULL
the	NULL
levels	NULL
of	NULL
hyperphosphorylated	NULL
Rb	NULL
in	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
and	NULL
SmadG-overexpressing	NULL
clones	NULL
(	NULL
HS-728ma6A	NULL
and	NULL
HS-728ma6B	NULL
)	NULL
,	NULL
resulting	NULL
in	NULL
a	NULL
time-dependent	NULL
increase	NULL
of	NULL
pRb	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
phosphorylation	NULL
status	NULL
of	NULL
pRb	NULL
seems	NULL
to	NULL
be	NULL
different	NULL
from	NULL
the	NULL
control	NULL
HS-72	NULL
cells	NULL
and	NULL
the	NULL
Smad6-	NULL
and	NULL
Smad7-overexpressing	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
control	NULL
HS-72C4	NULL
clone	NULL
was	NULL
almost	NULL
hyperphosphorylated	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
Smad	NULL
pressing	NULL
cells	NULL
were	NULL
equally	NULL
divided	NULL
between	NULL
hyperphosphorylated	NULL
Rb	NULL
and	NULL
pRb	NULL
,	NULL
and	NULL
the	NULL
SmadG-overexpressing	NULL
cells	NULL
were	NULL
biased	NULL
toward	NULL
pRb	NULL
.	NULL

We	NULL
have	NULL
no	NULL
ready	NULL
explanation	NULL
for	NULL
this	NULL
phenomenon	NULL
but	NULL
think	NULL
it	NULL
is	NULL
caused	NULL
by	NULL
the	NULL
differences	NULL
in	NULL
the	NULL
basal	NULL
growth	NULL
rate	NULL
of	NULL
the	NULL
control	NULL
cells	NULL
and	NULL
overexpressing	NULL
cells	NULL
.	NULL

Effects	NULL
of	NULL
Inhibitory	NULL
Smads	NULL
on	NULL
BMP-2-	NULL
and	NULL
Activin	NULL
A-induced	NULL
Apoptosis-Gel	NULL
electrophoresis	NULL
of	NULL
cellular	NULL
DNA	NULL
showed	NULL
that	NULL
fragmented	NULL
DNA	NULL
was	NULL
detected	NULL
much	NULL
less	NULL
in	NULL
-treated	NULL
Smad	NULL
?	NULL

7-overexpressing	NULL
clones	NULL
(	NULL
HS-728M1	NULL
and	NULL
HS-72SM2	NULL
)	NULL
and	NULL
hBMP-2-treated	NULL
Smad6-overexpressing	NULL
clones	NULL
(	NULL
HS-72Sma6A	NULL
and	NULL
HS-72Sma6B	NULL
)	NULL
than	NULL
in	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-720C4	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
nearly	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
fragmented	NULL
DNA	NULL
was	NULL
detected	NULL
in	NULL
activin	NULL
A-treated	NULL
Smad6-overexpressing	NULL
clones	NULL
(	NULL
HS-728ma6A	NULL
and	NULL
HS-72Sma6B	NULL
)	NULL
when	NULL
compared	NULL
with	NULL
Distinct	NULL
Functional	NULL
Roles	NULL
for	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

the	NULL
activin	NULL
A-treated	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
an	NULL
overexpression	NULL
of	NULL
Smad6	NULL
suppresses	NULL
hBMP-2-induced	NULL
apoptosis	NULL
but	NULL
not	NULL
activin	NULL
A-induced	NULL
apoptosis	NULL
.	NULL

Effects	NULL
of	NULL
Inhibitory	NULL
Smads	NULL
on	NULL
Activin	NULL
A-induced	NULL
Smad2	NULL
Phosphorylation-To	NULL
investigate	NULL
the	NULL
mechanisms	NULL
by	NULL
which	NULL
inhibitory	NULL
Smads	NULL
block	NULL
activin	NULL
A	NULL
signals	NULL
for	NULL
the	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
and	NULL
apoptosis	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
on	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
Smad2	NULL
by	NULL
activin	NULL
A	NULL
stimulation	NULL
with	NULL
immunoblot	NULL
analysis	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
phosphorylated	NULL
Smad2	NULL
(	NULL
approximately	NULL
56	NULL
kDa	NULL
)	NULL
was	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
30	NULL
min	NULL
after	NULL
activin	NULL
A	NULL
stimulation	NULL
in	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
.	NULL

However	NULL
,	NULL
no	NULL
phosphorylated	NULL
Smad2	NULL
was	NULL
detected	NULL
after	NULL
hBMP-2	NULL
stimulation	NULL
in	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
.	NULL

Smad7-overexpressing	NULL
clones	NULL
(	NULL
HS-728M1	NULL
and	NULL
HS-728M2	NULL
)	NULL
contained	NULL
undetectable	NULL
levels	NULL
of	NULL
phosphorylated	NULL
Smad2	NULL
when	NULL
cultured	NULL
with	NULL
activin	NULL
A	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
phosphorylated	NULL
Smad2	NULL
was	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
30	NULL
min	NULL
after	NULL
activin	NULL
A	NULL
stimulation	NULL
in	NULL
the	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
and	NULL
SmadG-overexpressing	NULL
clones	NULL
(	NULL
HS-728ma6A	NULL
and	NULL
HS-728ma6B	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

Effects	NULL
of	NULL
Inhibitory	NULL
Smads	NULL
on	NULL
BMP-2-induced	NULL
Smad1/	NULL
Smad5b	NULL
Phosphorylation-Next	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
expression	NULL
on	NULL
hBMP-2-induced	NULL
phosphorylation	NULL
of	NULL
Smad1/Smad5	NULL
by	NULL
immunoprecipitation-immunoblot	NULL
analysis	NULL
using	NULL
antiserum	NULL
specific	NULL
to	NULL
Smad	NULL
1/Smad5	NULL
phosphorylated	NULL
at	NULL
the	NULL
C-terminal	NULL
SSVS	NULL
motif	NULL
.	NULL

Untreated	NULL
control	NULL
clone	NULL
(	NULL
HS-72C4	NULL
)	NULL
contained	NULL
mostly	NULL
unphosphorylated	NULL
Smad	NULL
Upon	NULL
exposure	NULL
to	NULL
hBMP-2	NULL
,	NULL
the	NULL
bands	NULL
representing	NULL
phosphorylated	NULL
forms	NULL
of	NULL
Smad1/Smad5	NULL
were	NULL
detected	NULL
as	NULL
early	NULL
as	NULL
0.5	NULL
h	NULL
and	NULL
persisted	NULL
for	NULL
2	NULL
h	NULL
in	NULL
HS-72C4	NULL
clone	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
phosphorylation	NULL
of	NULL
Smad1/Smad5	NULL
did	NULL
not	NULL
occur	NULL
in	NULL
either	NULL
Smad6G-overexpressing	NULL
clone	NULL
(	NULL
HS-728ma6A	NULL
)	NULL
or	NULL
in	NULL
Smad	NULL
clone	NULL
(	NULL
HS-72SM1	NULL
)	NULL
for	NULL
2	NULL
h	NULL
after	NULL
hBMP-2	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
both	NULL
Smad6	NULL
and	NULL
Smad7	NULL
inhibit	NULL
hBMP-2	NULL
signals	NULL
by	NULL
blocking	NULL
the	NULL
C-terminal	NULL
phosphorylation	NULL
of	NULL
Smad1/Smad5	NULL
.	NULL

DISCUSSION	NULL
We	NULL
previously	NULL
demonstrated	NULL
that	NULL
activin	NULL
A	NULL
induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
in	NULL
HS-72	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
growth	NULL
arrest	NULL
was	NULL
mediated	NULL
by	NULL
induction	NULL
of	NULL
expression	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
inhibition	NULL
of	NULL
Rb	NULL
phosphorylation	NULL
by	NULL
blocking	NULL
the	NULL
activity	NULL
of	NULL
cyclin-dependent	NULL
kinase-4	NULL
(	NULL
25	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
reported	NULL
that	NULL
activin	NULL
A	NULL
showed	NULL
a	NULL
suppressive	NULL
effect	NULL
on	NULL
the	NULL
proliferation	NULL
of	NULL
human	NULL
B	NULL
cell	NULL
leukemias	NULL
(	NULL
39	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
found	NULL
that	NULL
not	NULL
only	NULL
activin	NULL
A	NULL
but	NULL
also	NULL
BMP-2	NULL
induced	NULL
profound	NULL
growth	NULL
arrest	NULL
of	NULL
HS-72	NULL
cells	NULL
and	NULL
the	NULL
human	NULL
myeloma	NULL
cells	NULL
line	NULL
U266B1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
the	NULL
possible	NULL
roles	NULL
of	NULL
activin	NULL
and	NULL
BMP	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
growth	NULL
of	NULL
B	NULL
lineage	NULL
cells	NULL
.	NULL

Recently	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
mRNA	NULL
expression	NULL
of	NULL
Smad	NULL
?	NULL

7	NULL
was	NULL
induced	NULL
by	NULL
activin	NULL
A	NULL
and	NULL
that	NULL
overexpression	NULL
of	NULL
mouse	NULL
Smad7	NULL
was	NULL
found	NULL
to	NULL
suppress	NULL
activin	NULL
A-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
,	NULL
phase	NULL
by	NULL
abolishing	NULL
the	NULL
activin	NULL
A-induced	NULL
expression	NULL
of	NULL
p21	NULL
``	NULL
``	NULL
``	NULL
``	NULL
and	NULL
hypophosphorylation	NULL
of	NULL
Rb	NULL
.	NULL

Furthermore	NULL
,	NULL
Smad	NULL
?	NULL

suppressed	NULL
activin	NULL
A-induced	NULL
apoptosis	NULL
in	NULL
HS-72	NULL
cells	NULL
(	NULL
32	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
mRNA	NULL
expression	NULL
of	NULL
Smad	NULL
?	NULL

7	NULL
was	NULL
induced	NULL
by	NULL
hBMP-2	NULL
,	NULL
and	NULL
an	NULL
overexpression	NULL
of	NULL
mouse	NULL
Smad	NULL
?	NULL

7	NULL
suppressed	NULL
hBMP-2-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
in	NULL
the	NULL
G	NULL
;	NULL
phase	NULL
by	NULL
abolishing	NULL
the	NULL
hBMP-2-induced	NULL
expression	NULL
of	NULL
p21	NULL
``	NULL
and	NULL
hypophosphorylation	NULL
of	NULL
Rb	NULL
.	NULL

Furthermore	NULL
,	NULL
Smad	NULL
?	NULL

7	NULL
suppressed	NULL
hBMP-2-induced	NULL
apoptosis	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
Smad	NULL
?	NULL

is	NULL
an	NULL
activin	NULL
A-	NULL
and	NULL
hBMP-2-inducible	NULL
inhibitor	NULL
of	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
in	NULL
HS-72	NULL
cells	NULL
stimulated	NULL
with	NULL
activin	NULL
A	NULL
and	NULL
hBMP-2	NULL
,	NULL
respectively	NULL
,	NULL
suggesting	NULL
that	NULL
Smad	NULL
?	NULL

may	NULL
participate	NULL
in	NULL
negative	NULL
feedback	NULL
loops	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Distinct	NULL
Functional	NULL
Roles	NULL
for	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

A	NULL
B	NULL
HS-72C4	NULL
HS-72SM1	NULL
HS-72SM2	NULL
HS-72C4	NULL
hBMP-2	NULL
=op	NULL
=	NULL
#	NULL
=	NULL
+	NULL
hBMP-2	NULL
=	NULL
+	NULL
13641	NULL
C	NULL
m	NULL
<	NULL
8	NULL
€	NULL
«	NULL
©	NULL
fol	NULL
&	NULL
&	NULL
E	NULL
E	NULL
st	NULL
E	NULL
3	NULL
s	NULL
i	NULL
$	NULL
o	NULL
f	NULL
of	NULL
N	NULL
N	NULL
h	NULL
E	NULL
m	NULL
th	NULL
t	NULL
t	NULL
t	NULL
t	NULL
I	NULL
E	NULL
Mo-	NULL
x	NULL
+o	NULL
o=	NULL
+	NULL
Activin	NULL
A	NULL
=o	NULL
#	NULL
=	NULL
o	NULL
o=	NULL
o+	NULL
#	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Effects	NULL
of	NULL
ectopic	NULL
expression	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
on	NULL
the	NULL
apoptosis	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
and	NULL
were	NULL
cultured	NULL
with	NULL
or	NULL
without	NULL
activin	NULL
A	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

(	NULL
C	NULL
)	NULL
for	NULL
86	NULL
h.	NULL
The	NULL
DNAs	NULL
were	NULL
analyzed	NULL
for	NULL
fragmentation	NULL
in	NULL
an	NULL
agarose	NULL
gel	NULL
.	NULL

Lane	NULL
M	NULL
,	NULL
super	NULL
ladder	NULL
low	NULL
double-stranded	NULL
DNA	NULL
marker	NULL
kit	NULL
(	NULL
Gen	NULL
Sura	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
,	NULL
Del	NULL
Mar	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

A	NULL
HS-720C4	NULL
hBMP-2	NULL
Activin	NULL
A	NULL
h	NULL
kDa	NULL
0	NULL
05	NULL
1	NULL
3	NULL
0	NULL
0.5	NULL
1	NULL
3	NULL
__	NULL
___	NULL
--	NULL
-	NULL
Phosphorylated	NULL
Smad2	NULL
46	NULL
HS-72C4	NULL
HS-72SM1	NULL
HS-725m2	NULL
0	NULL
05	NULL
1	NULL
3	NULL
0	NULL
05	NULL
1	NULL
3	NULL
0	NULL
05	NULL
1	NULL
3	NULL
h	NULL
kDa	NULL
fang	NULL
-	NULL
A	NULL
o	NULL
ie	NULL
e	NULL
+	NULL
Phosphorylated	NULL
|-	NULL
2	NULL
trate	NULL
met	NULL
4	NULL
fsa	NULL
-	NULL
46	NULL
BMIBUB-B	NULL
]	NULL
bu	NULL
__	NULL
_	NULL
.	NULL

ln	NULL
nen	NULL
m	NULL
mn	NULL
mae	NULL
ae	NULL
meee	NULL
Ston	NULL
|	NULL
C	NULL
HS-720C4	NULL
_	NULL
HS-72Sma6A	NULL
|	NULL
HS-72Sma6B	NULL
0	NULL
05	NULL
1	NULL
3	NULL
0	NULL
05	NULL
1	NULL
3	NULL
0	NULL
05	NULL
i	NULL
3	NULL
h	NULL
kDa	NULL
*	NULL
Woe	NULL
?	NULL

Nem	NULL
racy	NULL
Nows	NULL
hae	NULL
:	NULL
No	NULL
66	NULL
Phosphorylated	NULL
Smadg-	NULL
»	NULL
-	NULL
-z	NULL
ss	NULL
Rumer	NULL
w	NULL
-~	NULL
-	NULL
46	NULL
SMAU2-Ie-|	NULL
~-~	NULL
--	NULL
--	NULL
cee	NULL
me	NULL
matt	NULL
|	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Effects	NULL
of	NULL
ectopic	NULL
expression	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
on	NULL
activin	NULL
A-induced	NULL
phosphorylation	NULL
of	NULL
Smad2	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
activin	NULL
A	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
and	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
activin	NULL
A	NULL
(	NULL
50	NULL
ng/m	NULL
!	NULL
)	NULL

for	NULL
the	NULL
times	NULL
indicated	NULL
.	NULL

The	NULL
phosphorylation	NULL
status	NULL
of	NULL
Smad2	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
.	NULL

The	NULL
antibody	NULL
against	NULL
phosphorylated	NULL
Smad2	NULL
was	NULL
raised	NULL
after	NULL
immunizing	NULL
rabbits	NULL
with	NULL
the	NULL
synthetic	NULL
peptide	NULL
(	NULL
KKKSSMS	NULL
)	NULL
phosphorylated	NULL
at	NULL
the	NULL
last	NULL
two	NULL
serine	NULL
residues	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
Smad2	NULL
in	NULL
each	NULL
lane	NULL
was	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-mouse	NULL
Smad2	NULL
monoclonal	NULL
antibody	NULL
(	NULL
Transduction	NULL
Laboratories	NULL
,	NULL
Lexington	NULL
,	NULL
KY	NULL
)	NULL
and	NULL
is	NULL
shown	NULL
in	NULL
the	NULL
box	NULL
.	NULL

to	NULL
control	NULL
the	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
induced	NULL
by	NULL
both	NULL
activin	NULL
A	NULL
and	NULL
hBMP-2	NULL
.	NULL

It	NULL
was	NULL
previously	NULL
reported	NULL
that	NULL
pathway-restricted	NULL
Smads	NULL
,	NULL
Smad2	NULL
and	NULL
Smad3	NULL
,	NULL
act	NULL
in	NULL
the	NULL
TGF-B	NULL
and	NULL
activin	NULL
pathways	NULL
(	NULL
6-9	NULL
)	NULL
.	NULL

Smadl1	NULL
,	NULL
Smad5	NULL
,	NULL
and	NULL
Smad8	NULL
act	NULL
downstream	NULL
of	NULL
BMPs	NULL
(	NULL
10-16	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
Smad7	NULL
sup	NULL
HS-72C4	NULL
HS-72Sma6A	NULL
HS-72SM1	NULL
ho	NULL
0	NULL
050	NULL
2	NULL
0	NULL
0.5	NULL
2	NULL
0	NULL
05	NULL
2	NULL
Phosphorylated	NULL
Smad1i/Smads	NULL
-~	NULL
Smad1/Smad5	NULL
-.__E	NULL
won	NULL
wus	NULL
can	NULL
coe	NULL
come	NULL
cae	NULL
Gzp	NULL
come	NULL
cam	NULL
-	NULL
``	NULL
C.	NULL
oun	NULL
oop	NULL
cece	NULL
IgH	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Smad6	NULL
and	NULL
Smad7	NULL
inhibit	NULL
hBMP-2-mediated	NULL
Smad1/	NULL
Smad5	NULL
phosphorylation	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
hBMP-2	NULL
(	NULL
50	NULL
ng/ml	NULL
)	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
and	NULL
then	NULL
analyzed	NULL
for	NULL
the	NULL
phosphorylated	NULL
status	NULL
of	NULL
the	NULL
C-terminal	NULL
SSVS	NULL
motif	NULL
of	NULL
Smad1/Smad5	NULL
by	NULL
immunoprecipitation-immunoblot	NULL
analysis	NULL
.	NULL

The	NULL
goat	NULL
anti-Smad1l/	NULL
Smad5	NULL
serum	NULL
(	NULL
N-18	NULL
,	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
Inc.	NULL
)	NULL
was	NULL
used	NULL
for	NULL
immunoprecipitation	NULL
.	NULL

Anti-phosphorylated	NULL
Smad1l/Smad5	NULL
antibody	NULL
was	NULL
raised	NULL
against	NULL
KKKNPISSVS	NULL
phosphorylated	NULL
at	NULL
the	NULL
last	NULL
two	NULL
serine	NULL
residues	NULL
and	NULL
used	NULL
for	NULL
immunoblot	NULL
analysis	NULL
.	NULL

IgH	NULL
indicates	NULL
goat	NULL
immu-noglobulin	NULL
heavy	NULL
chains	NULL
.	NULL

pressed	NULL
an	NULL
activin	NULL
A-induced	NULL
phosphorylation	NULL
of	NULL
Smad2	NULL
and	NULL
a	NULL
BMP-2-induced	NULL
phosphorylation	NULL
of	NULL
Smad1/Smad5	NULL
,	NULL
which	NULL
occurs	NULL
on	NULL
two	NULL
serine	NULL
residues	NULL
in	NULL
a	NULL
Ser-Ser-X-Ser	NULL
motif	NULL
at	NULL
the	NULL
end	NULL
of	NULL
the	NULL
C-domain	NULL
of	NULL
the	NULL
Smads	NULL
(	NULL
16-18	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Smad7	NULL
suppresses	NULL
the	NULL
activin	NULL
A-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
by	NULL
attenuating	NULL
the	NULL
activin	NULL
A-induced	NULL
signals	NULL
for	NULL
phosphorylation	NULL
of	NULL
Smad2	NULL
,	NULL
and	NULL
the	NULL
BMP-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
by	NULL
attenuating	NULL
the	NULL
BMP-2-induced	NULL
signals	NULL
for	NULL
phosphorylation	NULL
of	NULL
Smad1/Smad5	NULL
.	NULL

In	NULL
Xenopus	NULL
embryos	NULL
,	NULL
ectopically	NULL
expressed	NULL
murine	NULL
Smad7	NULL
can	NULL
antagonize	NULL
activin-like	NULL
signaling	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Smad	NULL
?	NULL

7	NULL
has	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
and	NULL
inhibit	NULL
signaling	NULL
downstream	NULL
of	NULL
BMP	NULL
receptors	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Xenopus	NULL
Smad	NULL
?	NULL

is	NULL
most	NULL
closely	NULL
related	NULL
to	NULL
Smad	NULL
?	NULL

7	NULL
(	NULL
74	NULL
%	NULL
amino	NULL
acids	NULL
identical	NULL
)	NULL
and	NULL
acts	NULL
downstream	NULL
of	NULL
BMP	NULL
to	NULL
modulate	NULL
its	NULL
activity	NULL
during	NULL
vertebrate	NULL
embryonic	NULL
patterning	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Xenopus	NULL
Smad7	NULL
was	NULL
also	NULL
reported	NULL
to	NULL
inhibit	NULL
activin	NULL
and	NULL
BMP	NULL
signalings	NULL
in	NULL
animal	NULL
explants	NULL
(	NULL
41	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Xenopus	NULL
Smad	NULL
?	NULL

7	NULL
was	NULL
reported	NULL
to	NULL
block	NULL
signaling	NULL
mediated	NULL
by	NULL
the	NULL
activin	NULL
receptor	NULL
ALK-4	NULL
and	NULL
inhibit	NULL
BMP-4	NULL
signaling	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Taken	NULL
to-gether	NULL
,	NULL
these	NULL
findings	NULL
indicate	NULL
that	NULL
Smad7	NULL
may	NULL
act	NULL
as	NULL
a	NULL
general	NULL
inhibitor	NULL
of	NULL
the	NULL
TGF-	NULL
family	NULL
and	NULL
support	NULL
our	NULL
results	NULL
showing	NULL
that	NULL
Smad	NULL
?	NULL

inhibited	NULL
the	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
induced	NULL
by	NULL
both	NULL
activin	NULL
A	NULL
and	NULL
hBMP-2	NULL
.	NULL

Afrakhte	NULL
et	NULL
al	NULL
.	NULL

(	NULL
43	NULL
)	NULL
reported	NULL
that	NULL
the	NULL
mRNA	NULL
expression	NULL
of	NULL
Smad6	NULL
is	NULL
induced	NULL
by	NULL
multiple	NULL
stimuli	NULL
derived	NULL
from	NULL
the	NULL
various	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
13642	NULL
TGF-B	NULL
family	NULL
members	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
also	NULL
found	NULL
that	NULL
the	NULL
mRNA	NULL
expression	NULL
of	NULL
Smad6	NULL
was	NULL
induced	NULL
by	NULL
both	NULL
activin	NULL
A	NULL
and	NULL
hBMP-2	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
Smad6	NULL
was	NULL
an	NULL
hBMP-2-inducible	NULL
inhibitor	NULL
of	NULL
the	NULL
hBMP-2-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
in	NULL
HS-72	NULL
cells	NULL
,	NULL
suggesting	NULL
that	NULL
Smad6	NULL
may	NULL
participate	NULL
in	NULL
a	NULL
negative	NULL
feedback	NULL
loop	NULL
to	NULL
control	NULL
the	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
induced	NULL
by	NULL
hBMP-2	NULL
in	NULL
B	NULL
lineage	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
an	NULL
overexpression	NULL
of	NULL
Smad6	NULL
was	NULL
not	NULL
found	NULL
to	NULL
suppress	NULL
the	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
induced	NULL
by	NULL
activin	NULL
A	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
Smad6	NULL
blocked	NULL
a	NULL
BMP-2-induced	NULL
phosphorylation	NULL
of	NULL
Smad1/Smad5	NULL
,	NULL
suggesting	NULL
that	NULL
Smad6	NULL
suppresses	NULL
a	NULL
BMP-2-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
by	NULL
attenuating	NULL
the	NULL
BMP-2-induced	NULL
signals	NULL
for	NULL
phosphorylation	NULL
of	NULL
Smad1/Smad5	NULL
.	NULL

However	NULL
,	NULL
Smad6	NULL
did	NULL
not	NULL
suppress	NULL
activin	NULL
A-induced	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
because	NULL
of	NULL
its	NULL
incapability	NULL
for	NULL
attenuating	NULL
activin	NULL
A-induced	NULL
signals	NULL
for	NULL
phosphorylation	NULL
of	NULL
Smad2	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
Smad6	NULL
is	NULL
a	NULL
ligand-specific	NULL
inhibitor	NULL
of	NULL
growth	NULL
arrest	NULL
and	NULL
apoptosis	NULL
in	NULL
HS-72	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

7	NULL
exhibit	NULL
differential	NULL
inhibitory	NULL
activities	NULL
toward	NULL
BMP-	NULL
and	NULL
activin-induced	NULL
responses	NULL
in	NULL
mouse	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
endogenous	NULL
protein	NULL
levels	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
in	NULL
HS-72	NULL
cells	NULL
by	NULL
immunoblotting	NULL
.	NULL

Both	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

7	NULL
proteins	NULL
were	NULL
detected	NULL
in	NULL
Smad6-	NULL
and	NULL
Smad	NULL
pressing	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

However	NULL
,	NULL
the	NULL
endogenous	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

7	NULL
proteins	NULL
were	NULL
not	NULL
detected	NULL
,	NULL
even	NULL
when	NULL
HS-72	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
activin	NULL
A	NULL
and	NULL
BMP-2	NULL
for	NULL
12	NULL
and	NULL
24	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Whether	NULL
Smad6	NULL
and	NULL
Smad7	NULL
have	NULL
a	NULL
role	NULL
in	NULL
negative	NULL
feedback	NULL
control	NULL
in	NULL
myeloma	NULL
cells	NULL
will	NULL
be	NULL
the	NULL
subject	NULL
of	NULL
future	NULL
studies	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Dr.	NULL
K.	NULL
Miyazono	NULL
for	NULL
kindly	NULL
providing	NULL
us	NULL
with	NULL
plasmid	NULL
peDNAS-FLAG-Smad6	NULL
,	NULL
Dr.	NULL
Y.	NULL
Eto	NULL
(	NULL
Ajinomoto	NULL
Co.	NULL
,	NULL
Ltd.	NULL
)	NULL
for	NULL
activin	NULL
A	NULL
,	NULL
and	NULL
Yamanouchi	NULL
Pharmaceutical	NULL
Co.	NULL
,	NULL
Ltd.	NULL
for	NULL
hBMP-2	NULL
.	NULL

REFERENCES	NULL
.	NULL

Mathews	NULL
,	NULL
L.	NULL
S.	NULL
(	NULL
1994	NULL
)	NULL
Endocr	NULL
.	NULL

Rev	NULL
.	NULL

15	NULL
,	NULL
310-825	NULL
.	NULL

Massagué	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
85	NULL
,	NULL
947-950	NULL
.	NULL

Derynck	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Feng	NULL
,	NULL
X.	NULL
H.	NULL
(	NULL
1997	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
.	NULL

1888	NULL
,	NULL
F105-F150	NULL
.	NULL

Massagué	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

67	NULL
,	NULL
758-791	NULL
Heldin	NULL
,	NULL
C.-H.	NULL
,	NULL
Miyazono	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
ten	NULL
Dijke	NULL
,	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
890	NULL
,	NULL
465-471	NULL
.	NULL

Graff	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Bancel	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Melton	NULL
,	NULL
D.	NULL
A	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Cell	NULL
85	NULL
,	NULL
479-487	NULL
Zhang	NULL
,	NULL
Y.	NULL
,	NULL
Feng	NULL
,	NULL
X.-H.	NULL
,	NULL
Wu	NULL
,	NULL
R.-Y	NULL
.	NULL

,	NULL
and	NULL
Derynck	NULL
,	NULL
R.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
883	NULL
,	NULL
168-172	NULL
.	NULL

Eppert	NULL
,	NULL
K.	NULL
,	NULL
Scherer	NULL
,	NULL
S.	NULL
W.	NULL
,	NULL
Ozcelik	NULL
,	NULL
H.	NULL
,	NULL
Pirone	NULL
,	NULL
R.	NULL
,	NULL
Hoodless	NULL
,	NULL
P.	NULL
,	NULL
Kim	NULL
,	NULL
H.	NULL
,	NULL
Tsui	NULL
,	NULL
L.-C.	NULL
,	NULL
Bapat	NULL
,	NULL
B.	NULL
,	NULL
Gallinger	NULL
,	NULL
S.	NULL
,	NULL
Andrulis	NULL
,	NULL
I.	NULL
L.	NULL
,	NULL
Thomsen	NULL
,	NULL
G.	NULL
H.	NULL
,	NULL
Wrana	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Attisano	NULL
,	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
86	NULL
,	NULL
548-552	NULL
9	NULL
.	NULL

Nakao	NULL
,	NULL
A.	NULL
,	NULL
Imamura	NULL
,	NULL
T.	NULL
,	NULL
Souchelnytskyi	NULL
,	NULL
S.	NULL
,	NULL
Kawabata	NULL
,	NULL
M.	NULL
,	NULL
Ishisaki	NULL
,	NULL
A.	NULL
,	NULL
Oeda	NULL
,	NULL
E.	NULL
,	NULL
Tamaki	NULL
,	NULL
K.	NULL
,	NULL
Hanai	NULL
,	NULL
J.	NULL
,	NULL
Heldin	NULL
,	NULL
C.-H.	NULL
,	NULL
Miyazono	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
ten	NULL
Dijke	NULL
,	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
EMBO	NULL
J	NULL
16	NULL
,	NULL
5353-5362	NULL
10	NULL
.	NULL

Hoodless	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Haerry	NULL
,	NULL
T.	NULL
,	NULL
Abdollah	NULL
,	NULL
S.	NULL
,	NULL
Stapleton	NULL
,	NULL
M.	NULL
,	NULL
O'Conner	NULL
,	NULL
M.	NULL
B.	NULL
,	NULL
Attisano	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Wrana	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1996	NULL
)	NULL
Cell	NULL
85	NULL
,	NULL
489-500	NULL
g	NULL
n	NULL
g	NULL
pus	NULL
p	NULL
hop	NULL
Distinct	NULL
Functional	NULL
Roles	NULL
for	NULL
Smad6	NULL
and	NULL
Smad	NULL
?	NULL

11	NULL
.	NULL

Liu	NULL
,	NULL
F.	NULL
,	NULL
Hata	NULL
,	NULL
A.	NULL
,	NULL
Baker	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Doody	NULL
,	NULL
J.	NULL
,	NULL
Carcamo	NULL
,	NULL
J.	NULL
,	NULL
Harland	NULL
,	NULL
R.	NULL
M.	NULL
,	NULL
and	NULL
Massagué	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Nature	NULL
881	NULL
,	NULL
620-623	NULL
12	NULL
.	NULL

Suzuki	NULL
,	NULL
A.	NULL
,	NULL
Chang	NULL
,	NULL
C.	NULL
,	NULL
Yingling	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Wang	NULL
,	NULL
X.-F.	NULL
,	NULL
and	NULL
Hemmati-Brivanlou	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

184	NULL
,	NULL
402-405	NULL
13	NULL
.	NULL

Watanabe	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Suzuki	NULL
,	NULL
M.	NULL
,	NULL
Omori	NULL
,	NULL
Y.	NULL
,	NULL
Hishigaki	NULL
,	NULL
H.	NULL
,	NULL
Horie	NULL
,	NULL
M.	NULL
,	NULL
Kanemoto	NULL
,	NULL
N.	NULL
,	NULL
Fujiwara	NULL
,	NULL
T.	NULL
,	NULL
Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Takahashi	NULL
,	NULL
E.	NULL
(	NULL
1997	NULL
)	NULL
Genomics	NULL
42	NULL
,	NULL
446-451	NULL
14	NULL
.	NULL

Chen	NULL
,	NULL
Y.	NULL
,	NULL
Bhushan	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Vale	NULL
,	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

94	NULL
,	NULL
12938-12943	NULL
15	NULL
.	NULL

Tamaki	NULL
,	NULL
K.	NULL
,	NULL
Souchelnytskyi	NULL
,	NULL
S.	NULL
,	NULL
Itoh	NULL
,	NULL
S.	NULL
,	NULL
Nakao	NULL
,	NULL
A.	NULL
,	NULL
Sampath	NULL
,	NULL
K.	NULL
,	NULL
Heldin	NULL
,	NULL
C-H.	NULL
,	NULL
and	NULL
ten	NULL
Dijke	NULL
,	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Physiol	NULL
.	NULL

177	NULL
,	NULL
855-863	NULL
16	NULL
.	NULL

Macias-Silva	NULL
,	NULL
M.	NULL
,	NULL
Hoodless	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
Tang	NULL
,	NULL
S.	NULL
J.	NULL
,	NULL
Buchwald	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Wrana	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
25628-25636	NULL
17	NULL
.	NULL

Souchelnytskyi	NULL
,	NULL
S.	NULL
,	NULL
Tamaki	NULL
,	NULL
K.	NULL
,	NULL
Engstrom	NULL
,	NULL
U.	NULL
,	NULL
Wernstedt	NULL
,	NULL
C.	NULL
,	NULL
ten	NULL
Dijke	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Heldin	NULL
,	NULL
C.-H.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
28107-28115	NULL
18	NULL
.	NULL

Abdollah	NULL
,	NULL
S.	NULL
,	NULL
Macifas-Silva	NULL
,	NULL
M.	NULL
,	NULL
Tsukazaki	NULL
,	NULL
T.	NULL
,	NULL
Hayashi	NULL
,	NULL
H.	NULL
,	NULL
Attisano	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Wrana	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1997	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

272	NULL
,	NULL
27678-27685	NULL
19	NULL
.	NULL

Lagna	NULL
,	NULL
G.	NULL
,	NULL
Hata	NULL
,	NULL
A.	NULL
,	NULL
Hemmati-Brivanlou	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Massagué	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Nature	NULL
383	NULL
,	NULL
832-836	NULL
20	NULL
.	NULL

Zhang	NULL
,	NULL
Y.	NULL
,	NULL
Musci	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Derynck	NULL
,	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
Curr	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
270-276	NULL
21	NULL
.	NULL

Kawabata	NULL
,	NULL
M.	NULL
,	NULL
Inoue	NULL
,	NULL
H.	NULL
,	NULL
Hanyu	NULL
,	NULL
A.	NULL
,	NULL
Imamura	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Miyazono	NULL
,	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

17	NULL
,	NULL
4056-4065	NULL
22	NULL
.	NULL

Chen	NULL
,	NULL
X.	NULL
,	NULL
Rubock	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Whitman	NULL
,	NULL
M.	NULL
(	NULL
1996	NULL
)	NULL
Nature	NULL
383	NULL
,	NULL
691-696	NULL
23	NULL
.	NULL

Chen	NULL
,	NULL
X.	NULL
,	NULL
Weisberg	NULL
,	NULL
E.	NULL
,	NULL
Fridmacher	NULL
,	NULL
V.	NULL
,	NULL
Watanabe	NULL
,	NULL
M.	NULL
,	NULL
Naco	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Whitman	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
889	NULL
,	NULL
85-89	NULL
24	NULL
.	NULL

Kim	NULL
,	NULL
J.	NULL
,	NULL
Johnson	NULL
,	NULL
K.	NULL
,	NULL
Chen	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
Carroll	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Laughon	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Nature	NULL
388	NULL
,	NULL
304-308	NULL
25	NULL
.	NULL

Yamato	NULL
,	NULL
K.	NULL
,	NULL
Koseki	NULL
,	NULL
T.	NULL
,	NULL
Obguchi	NULL
,	NULL
M.	NULL
,	NULL
Kizaki	NULL
,	NULL
M.	NULL
,	NULL
Ikeda	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Nishibara	NULL
,	NULL
T.	NULL
(	NULL
1997	NULL
)	NULL
Mol	NULL
.	NULL

Endocrinol	NULL
.	NULL

11	NULL
,	NULL
1044-1052	NULL
26	NULL
.	NULL

Imamura	NULL
,	NULL
T.	NULL
,	NULL
Takase	NULL
,	NULL
M.	NULL
,	NULL
Nishihara	NULL
,	NULL
A.	NULL
,	NULL
Oeda	NULL
,	NULL
E.	NULL
,	NULL
Hanai	NULL
,	NULL
J.	NULL
,	NULL
Kawabata	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Miyazono	NULL
,	NULL
K.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
398	NULL
,	NULL
622-626	NULL
27	NULL
.	NULL

Hayashi	NULL
,	NULL
H.	NULL
,	NULL
Abdollah	NULL
,	NULL
S.	NULL
,	NULL
Qiu	NULL
,	NULL
Y	NULL
.	NULL

B.	NULL
,	NULL
Cai	NULL
,	NULL
J.	NULL
X.	NULL
,	NULL
Xu	NULL
,	NULL
Y.	NULL
Y.	NULL
,	NULL
Grinnell	NULL
,	NULL
B.	NULL
W.	NULL
,	NULL
Richardson	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Topper	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
Gimbrone	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Jr.	NULL
,	NULL
Wrana	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
Falb	NULL
,	NULL
D.	NULL
(	NULL
1997	NULL
)	NULL
Cell	NULL
89	NULL
,	NULL
1165-1173	NULL
28	NULL
.	NULL

Nakao	NULL
,	NULL
A.	NULL
,	NULL
Afrakhte	NULL
,	NULL
M.	NULL
,	NULL
Morén	NULL
,	NULL
A.	NULL
,	NULL
Nakayama	NULL
,	NULL
T.	NULL
,	NULL
Christian	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Heuchel	NULL
,	NULL
R.	NULL
,	NULL
Itoh	NULL
,	NULL
S.	NULL
,	NULL
Kawabata	NULL
,	NULL
M.	NULL
,	NULL
Heldin	NULL
,	NULL
N.-E.	NULL
,	NULL
Heldin	NULL
,	NULL
C.-H.	NULL
,	NULL
and	NULL
ten	NULL
Dijke	NULL
,	NULL
P.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
889	NULL
,	NULL
681-635	NULL
29	NULL
.	NULL

Souchelnytskyi	NULL
,	NULL
S.	NULL
,	NULL
Nakayama	NULL
,	NULL
T.	NULL
,	NULL
Nakao	NULL
,	NULL
A.	NULL
,	NULL
Morén	NULL
,	NULL
A.	NULL
,	NULL
Heldin	NULL
,	NULL
C.-H.	NULL
,	NULL
Christian	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
and	NULL
ten	NULL
Dijke	NULL
,	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
25364-25370	NULL
30	NULL
.	NULL

Hata	NULL
,	NULL
A.	NULL
,	NULL
Lagna	NULL
,	NULL
G.	NULL
,	NULL
Massagué	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Hemmati-Brivanlou	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

12	NULL
,	NULL
186-197	NULL
31	NULL
.	NULL

Nakayama	NULL
,	NULL
T.	NULL
,	NULL
Gardner	NULL
,	NULL
H.	NULL
,	NULL
Berg	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
and	NULL
Christian	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
Genes	NULL
Cells	NULL
8	NULL
,	NULL
387-394	NULL
82	NULL
.	NULL

Ishisaki	NULL
,	NULL
A.	NULL
,	NULL
Yamato	NULL
,	NULL
K.	NULL
,	NULL
Nakao	NULL
,	NULL
A.	NULL
,	NULL
Nonaka	NULL
,	NULL
K.	NULL
,	NULL
Ohguchi	NULL
,	NULL
M.	NULL
,	NULL
ten	NULL
Dijke	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Nishihara	NULL
,	NULL
T.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

278	NULL
,	NULL
24298-24296	NULL
33	NULL
.	NULL

Nishibara	NULL
,	NULL
T.	NULL
,	NULL
Okahashi	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
Ueda	NULL
,	NULL
N.	NULL
(	NULL
1993	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

197	NULL
,	NULL
985-991	NULL
384	NULL
.	NULL

Perandones	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Hera	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
Peckham	NULL
,	NULL
D.	NULL
,	NULL
Stunz	NULL
,	NULL
L.	NULL
L.	NULL
,	NULL
and	NULL
Ashman	NULL
,	NULL
R.	NULL
F.	NULL
(	NULL
19938	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

151	NULL
,	NULL
3521-3529	NULL
35	NULL
.	NULL

Moore	NULL
,	NULL
K.	NULL
J.	NULL
,	NULL
and	NULL
Matiashewski	NULL
,	NULL
G.	NULL
(	NULL
1994	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

152	NULL
,	NULL
2980-2937	NULL
36	NULL
.	NULL

Persson	NULL
,	NULL
U.	NULL
,	NULL
Izumi	NULL
,	NULL
H.	NULL
,	NULL
Souchelnytskyi	NULL
,	NULL
S.	NULL
,	NULL
Itoh	NULL
,	NULL
S.	NULL
,	NULL
Grimsby	NULL
,	NULL
S.	NULL
,	NULL
Engstrom	NULL
,	NULL
U.	NULL
,	NULL
Heldin	NULL
,	NULL
C-H.	NULL
,	NULL
Funa	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
ten	NULL
Dijke	NULL
,	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
FEBS	NULL
Lett	NULL
.	NULL

484	NULL
,	NULL
88-87	NULL
37	NULL
.	NULL

Tokunaga	NULL
,	NULL
K.	NULL
,	NULL
Nakamura	NULL
,	NULL
Y.	NULL
,	NULL
Sakata	NULL
,	NULL
K.	NULL
,	NULL
Fujimori	NULL
,	NULL
K.	NULL
,	NULL
Ohkubo	NULL
,	NULL
M.	NULL
,	NULL
Sawada	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Sakiyama	NULL
,	NULL
S.	NULL
(	NULL
1987	NULL
)	NULL
Cancer	NULL
Res	NULL
.	NULL

47	NULL
,	NULL
5616-5619	NULL
38	NULL
.	NULL

Sugito	NULL
,	NULL
S.	NULL
,	NULL
Yamato	NULL
,	NULL
K.	NULL
,	NULL
Sameshima	NULL
,	NULL
Y.	NULL
,	NULL
Yokota	NULL
,	NULL
J.	NULL
,	NULL
Yano	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Miyoshi	NULL
,	NULL
I	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
49	NULL
,	NULL
880-885	NULL
39	NULL
.	NULL

Nishibara	NULL
,	NULL
T.	NULL
,	NULL
Ohsaki	NULL
,	NULL
Y.	NULL
,	NULL
Ueda	NULL
,	NULL
N.	NULL
,	NULL
Koseki	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Eto	NULL
,	NULL
Y	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
J.	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
.	NULL

15	NULL
,	NULL
509-516	NULL
40	NULL
.	NULL

Nakayama	NULL
,	NULL
T.	NULL
,	NULL
Snyder	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Grewal	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
Teunezumi	NULL
,	NULL
K.	NULL
,	NULL
Tabata	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Christian	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1988	NULL
)	NULL
Development	NULL
125	NULL
,	NULL
857-867	NULL
41	NULL
.	NULL

Casellas	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Brivanlou	NULL
A.	NULL
H.	NULL
(	NULL
1998	NULL
)	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

198	NULL
,	NULL
1-12	NULL
42	NULL
.	NULL

Bhushan	NULL
,	NULL
A.	NULL
,	NULL
Chen	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Vale	NULL
,	NULL
W.	NULL
(	NULL
1998	NULL
)	NULL
Dev	NULL
.	NULL

Biol	NULL
.	NULL

200	NULL
,	NULL
260-268	NULL
43	NULL
.	NULL

Afrakhte	NULL
,	NULL
M.	NULL
,	NULL
Morén	NULL
,	NULL
A.	NULL
,	NULL
Jossan	NULL
,	NULL
S.	NULL
,	NULL
Itoh	NULL
,	NULL
S.	NULL
,	NULL
Sampath	NULL
,	NULL
K.	NULL
,	NULL
Westermark	NULL
,	NULL
B.	NULL
,	NULL
Heldin	NULL
,	NULL
C.-H.	NULL
,	NULL
Heldin	NULL
,	NULL
N.-E.	NULL
,	NULL
and	NULL
ten	NULL
Dijke	NULL
,	NULL
P.	NULL
(	NULL
1998	NULL
)	NULL
Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Commun	NULL
.	NULL

249	NULL
,	NULL
505-511	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Differential	NULL
Inhibition	NULL
of	NULL
Smad6	NULL
and	NULL
Smad7	NULL
on	NULL
Bone	NULL
Morphogenetic	NULL
Protein-	NULL
and	NULL
Activin-mediated	NULL
Growth	NULL
Arrest	NULL
and	NULL
Apoptosis	NULL
in	NULL
B	NULL
Cells	NULL
Akira	NULL
Ishisaki	NULL
,	NULL
Kenji	NULL
Yamato	NULL
,	NULL
Shinichi	NULL
Hashimoto	NULL
,	NULL
Atsuhito	NULL
Nakao	NULL
,	NULL
Kiyoshi	NULL
Tamaki	NULL
,	NULL
Koji	NULL
Nonaka	NULL
,	NULL
Peter	NULL
ten	NULL
Dijke	NULL
,	NULL
Hiromu	NULL
Sugino	NULL
and	NULL
Tatsuji	NULL
Nishihara	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

1999	NULL
,	NULL
274:13637-13642.	NULL
doi	NULL
:	NULL
10.1074/jb0.274.19.13637	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
http	NULL
:	NULL
/www.jbe.org/content/274/19/13637	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
43	NULL
references	NULL
,	NULL
13	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
3637	NULL
.full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

